BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Biotech Whisperer John Edwards Seeks the Extraordinary at Verseau

  John Edwards, newly-appointed CEO of Verseau Therapeutics, is continually searching for something special.

  June 10, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Drug Development

  Aducanumab Saga Continues as FDA Committee Members Resign Over Approval

  David S. Knopman and Joel S. Perlmutter both resigned from the committee after the approval of the drug aducanumab.

  June 10, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  Five Collaborations Unlocking Faster Drug Development this Week

  This week, multiple companies have partnered in attempts to bring forth new therapies. BioSpace takes a look at some of these announcements.

  June 10, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Ocugen Faces Major Slowdown for COVID-19 Vaccine as FDA Recommends BLA

  The Pennsylvania-based eye disease company had to change its application from an Emergency Use Authorization to a full BLA approval.

  June 10, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Genetown

  Seres Bolsters Rationale Behind GVHD, Cancer Programs at ASCO Meeting

  With an oral presentation and a poster at the ASCO Annual Meeting this year, Seres Therapeutics sought to bolster the case for two of its microbiome therapeutics programs.

  June 10, 2021

   · 

  4 min read

   · 

  Mark Zipkin
• 

  Business

  Funding News: Synthekine, Bright Peak Each Raise $107 Million in Series B Rounds

  Synthekine and Bright Peak made announcements on their Series B rounds, while Hawthorne Effect and Owl Peak Labs also secured their funding. Let us take a look.

  June 10, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Lone Star Bio

  Research Roundup: A Cognitive Clock to Measure Brain Health and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  June 10, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Career Advice

  The Art of Drafting a Perfect Cover Letter in 2021

  If you’re considering preparing for your next interview, know that you need to learn the art of drafting a perfect cover letter to show that you’re a great match for the position.

  June 10, 2021

   · 

  2 min read

   · 

  Brandi Marcene
• 

  Drug Development

  Phase III Results Support BMS’ CAR-T Cell Therapy Breyanzi in Relapsed/Refractory B-Cell Lymphoma

  The new study findings may pave the way for Bristol Myers Squibb to receive additional approval for Breyanzi in a vulnerable patient population.

  June 10, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Career Advice

  Biotech In-Demand Jobs: Remote Workers

  What are the benefits of becoming a remote worker? Let’s explore together.

  June 10, 2021

   · 

  4 min read

   · 

  Kymberlie Krieger